BIBLIOGRAFÍA:
1. Arpino G,
Bardou VJ,
Clark GM,
Elledge RM (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Breast Cancer Res 6(3):R149–R156
2.
Arps DP,
Healy P,
Zhao L,
Kleer CG,
Pang JC (2013) Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
Breast Cancer Res Treat 138(3):719–726
3. Biglia N,
Mariani L,
Sgro L,
Mininanni P,
Moggio G,
Sismondi P (2007) Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis,
surgical and medical treatment.
Endocr Relat Cancer 14(3):549–567
4.
Boetes C,
Mus RD,
Holland R,
Barentsz JO,
Strijk SP,
Wobbes T,
Hendriks JH,
Ruys SH (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.
Radiology 197(3):743–747
5.
Brandao Alice,
(2012) Resonancia Magnética de la mama.
Editorial Amolca
6.
Hayes C,
Padhani AR,
Leach MO.
Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging.
NMR Biomed.
2002;15:154-63.
7. Menezes Gisela L,
Van der Bosch M AJJ,
Postma L,
El Sharouni MA,
Verkooijen HM,
Van Diest PJ,
Pijnappel RM.
Invasive ductolobular carcinoma of the breast: spectrum of mamography,
ultrasound and magnetic resonance imaging findings correlated with proportion of the lobular component. Springerplus. 2013; 2: 621
8. Michael M,
Garzoli E,
Reiner CS (2008) Mammography,
sonography and MRI for detection and characterization of invasive lobular carcinoma of the breast.
Breast Dis 30:21–30
9.
Moran MS,
Yang Q,
Haffty BG (2009) The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features,
long-term outcomes,
and molecular expression of COX-2,
Bcl-2,
and p53 as a function of histology.
Breast J 15(6):571–578
10.
Partridge SC,
Gibbs JE,
Lu Y,
Esserman LJ,
Sudilovsky D,
Hylton NM.
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
AJR Am J Roentgenol.
2002;179:1193-9.
11.
Rodenko GN,
Harms SE,
Pruneda JM,
Farrell RS,
Jr,
Evans WP,
Copit DS,
Krakos PA,
Flamig DP.
MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol. 1996;167(6):1415–1419
12. Rosen EL,
Blackwell KL,
Baker JA,
Soo MS,
Bentley RC,
Yu D,
et-al.
Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
AJR Am J Roentgenol.
2003;181:1275-82
13.
Londero V,
Bazzocchi M,
Frate CD,
Puglisi F,
Di Loreto C,
Francescutti G,
et-al.
Locally advanced breast cancer: comparison of mammography,
sonography and MR imaging in evaluation of residual disease in women receiving neoadyuvant chemotherapy.
Eur Radiol.
2004;14:1371-9.